Novel target antigens to improve the efficacy of immunotherapeutics in multiple myeloma
Yu-Tzu Tai • 8 Aug 2022
The role of PHF19 in multiple myeloma & its potential as a therapeutic target
Tengteng Yu • 27 Aug 2022
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.